Reuters Health News | August 27, 2018. Pfizer Inc said on Monday that its drug tafamidis reduced the risk of death for patients with transthyretin ... read more
Drug for transthyretin amyloid cardiomyopathy curbs deaths by 30% in study
Drug for transthyretin amyloid cardiomyopathy curbs deaths by 30% in study